Company intelligence
Genoplex.ai
Redefining Care with AI that Connects Patients to Life-Saving Therapies
About Genoplex.ai
Genoplex.ai is a health technology company focused on transforming how patients are identified, referred, and connected to personalized medicines and advanced therapies. Genoplex.ai has developed Advanced Therapy Connect™, a digital solution powered by agentic AI - a new class of autonomous software agents and AI medical scribes that streamline the end-to-end care navigation process. The core of the Genoplex platform is its agentic AI architecture - a system of purpose-built digital agents and medical AI scribes trained to interpret both structured and unstructured EHR data to identify eligible patients for personalized medicines and advanced therapies. These AI agents operate semi-autonomously across workflows, continuously ingesting data from clinical notes, lab values, biomarkers and diagnosis codes to flag patients who meet specific clinical criteria. This underlying system is powered by Genoplex Engage™ - a proprietary AI orchestration engine, which coordinates these tasks in real-time with a plug-and-play digital intake portal that interfaces seamlessly with provider systems via secure integrations. Our Vision for the Future We are driven by the belief that patients should never face unnecessary delays in accessing potentially curative treatments. We envision a future where cutting-edge science will empower patients to take control of their healing journeys. Join us in our mission to help millions of patients around the world take control of their healing journeys for their chronic diseases. Together, we can redefine healthcare access and unlock the full potential of advanced therapies. For more information, contact us at info@genoplex.ai Or... Visit https://www.genoplex.ai to request to request a demo.
Verified activity
Signals from Genoplex.ai
3 published signals
Research & Knowledge
Genoplex.ai spoke with leaders from Novartis, Ratio Therapeutics, Perspective Therapeutics, Convergent Therapeutics, and Plus Therapeutics (rebranded to Cerenome) about the rapidly evolving field of radiopharmaceuticals.
Reported by Christopher Leidli
Presence & Recognition
Genoplex.ai is attending the Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa in Phoenix.
Reported by Genoplex.ai
Presence & Recognition
Genoplex.ai is attending the Cell & Gene Meeting on the Mesa in Phoenix from October 4 to 7, focusing on clinical-to-commercial transition, referral-to-infusion gaps, and access infrastructure.
Reported by Christopher Leidli